Zonisamide Capsule
Product Images NDC 70518-4349

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 70518-4349). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Zonisamide 50 mg capsule packaging label showing quantity of 100 per box. The label indicates the capsules are white and manufactured by Aurobindo Pharma in Dayton, NJ, with repackaging by RemedyRepack Inc., Indiana, PA. Storage instructions and a note to consult the insert for dosage are included on the label.*
FDA Label Image

Mm2 (Zonisamide 50mg 70518 4349 01)

Mm2 (Zonisamide 50mg 70518 4349 01)
Zonisamide 50 mg capsule label showing a single oral capsule quantity. The label includes the NDC number 70518-4349-01, manufacturing information by Aurobindo Pharma in Dayton, NJ, and repackaging by RemedyRepack Inc., Indiana, PA. Storage instructions and child safety warnings are also present.*
FDA Label Image

Figure 1 Proportion Of Patients Achieving Differing Levels (Zonisamide Fig1)

Figure 1 Proportion Of Patients Achieving Differing Levels (Zonisamide Fig1)
A line graph comparing the percentage reduction in all partial seizure rate for patients treated with Zonisamide capsules versus placebo. The graph plots percentage of patients on the x-axis against percentage reduction in seizures on the y-axis, showing Zonisamide treatment leads to greater improvement compared to placebo.*
FDA Label Image

Chemical Structure (Zonisamide Str)

Chemical Structure (Zonisamide Str)
Chemical structure illustration of the active ingredient zonisamide, showing a benzisoxazole ring with a sulfonamide group attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.